Loading insider details...
Beta
Latest Form 4 (Jul 30, 2026): Sale of 1,250 NBIX shares, $227.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 30, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 1,250 | $227.5K |
| Jun 26, 2026 | ARVINAS, INC. (ARVN) | Grant/Award | 15,527 | n/a |
| Jun 8, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 1,250 | $210.1K |
| May 29, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 1,284 | n/a |
| May 21, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,659 | n/a |
| May 15, 2026 | CVS HEALTH Corp (CVS) | Grant/Award | 1,447 | $140.6K |
| May 14, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 3,810 | $590.6K |
| Jan 23, 2026 | GLOBUS MEDICAL INC (GMED) | Grant/Award | 15,000 | n/a |
| Jan 12, 2026 | GLOBUS MEDICAL INC (GMED) | Sale | 2,000 | $202.2K |
| Dec 17, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 8,276 | $764.3K |